Tamás Ágh MD MSc PhD DrHabil graduated from the Semmelweis Medical University (MD, 2006), the Corvinus University of Budapest (MSc Physician-Economist, 2010), the Semmelweis University School of PhD Studies (PhD in Pharmacoeconomics, 2013) and the University of Pecs Doctoral School of Health Sciences (DrHabil in Health Sciences, 2020). He specialized in family medicine in 2010. Dr. Ágh is the Director of Strategy of the Syreon Research Institute. He is also a Research Associate Professor & the Head of the Medication Adherence Research Group at the Center for Health Technology Assessment and Pharmacoeconomic Research at the University of Pécs and has been practicing as a medical doctor since 2006. With a professional background spanning over 15 years, his areas of specialization in health economics and outcome research include medication adherence, patient-reported outcome measures, health technology assessment, data analysis and sustainability. He serves as the President of the ESPACOMP International Society of Medication Adherence (for 2025) and leadership member of the ISPOR Medication Adherence and Persistence Special Interest Group.